Real-World Effectiveness of Mepolizumab in Patients with Allergic and Non-Allergic Asthma.

Jared SilverAndrea SteffensBenjamin ChastekArijita Deb

Published in: Journal of asthma and allergy (2024)

Mepolizumab significantly reduced asthma exacerbations and OCS use in patients with allergic and non-allergic asthma, suggesting that mepolizumab provides real-world benefit in severe asthma irrespective of whether a patient has an allergic phenotype.

Keyphrases

allergic rhinitis
chronic obstructive pulmonary disease
lung function
randomized controlled trial
systematic review
cystic fibrosis
atopic dermatitis
air pollution